These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26316923)

  • 21. Haemoglobin A1c: evaluation of a new HbA1c point-of-care analyser Bio-Rad in2it in comparison with the DCA 2000 and central laboratory analysers.
    Yeo CP; Tan CH; Jacob E
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):373-6. PubMed ID: 19487414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Availability and analytical quality of hemoglobin A1c point-of-care testing in general practitioners' offices are associated with better glycemic control in type 2 diabetes.
    Tollånes MC; Jenum AK; Berg TJ; Løvaas KF; Cooper JG; Sandberg S
    Clin Chem Lab Med; 2020 Jul; 58(8):1349-1356. PubMed ID: 32229656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nurse-based evaluation of point-of-care assays for glycated haemoglobin.
    St John A; Davis TM; Goodall I; Townsend MA; Price CP
    Clin Chim Acta; 2006 Mar; 365(1-2):257-63. PubMed ID: 16202401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use.
    Sacks DB; Kirkman MS; Little RR
    Diabetes Care; 2024 Jul; 47(7):1104-1110. PubMed ID: 38552140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biomarkers in diabetes mellitus: contributions and discrepancies of new technologies. A case report].
    Mialon F; Catargi B; Rami L; Barat P; Bedel A; Lacape G; Bérard AM; Beauvieux MC
    Ann Biol Clin (Paris); 2021 Oct; 79(5):445-451. PubMed ID: 34782310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter assessment of a hemoglobin A1c point-of-care device for diagnosis of diabetes mellitus.
    Sobolesky PM; Smith BE; Saenger AK; Schulz K; Apple FS; Scott MG; Wu AHB; Little RR; Fitzgerald RL
    Clin Biochem; 2018 Nov; 61():18-22. PubMed ID: 30236830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.
    Wood JR; Kaminski BM; Kollman C; Beck RW; Hall CA; Yun JP; Cengiz E; Haller MJ; Hassan K; Klingensmith GJ; Tamborlane WV
    J Diabetes Sci Technol; 2012 Mar; 6(2):380-6. PubMed ID: 22538150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Point-of-Care Hemoglobin A1c Testing on Population Health-Based Onsite Testing Adherence: A Primary-Care Quality Improvement Study.
    Crocker JB; Lynch SH; Guarino AJ; Lewandrowski K
    J Diabetes Sci Technol; 2021 May; 15(3):561-567. PubMed ID: 33233954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy and Precision of a Point-of-Care HbA1c Test.
    Arnold WD; Kupfer K; Little RR; Amar M; Horowitz B; Godbole N; Hvidsten Swensen M; Li Y; San George RC
    J Diabetes Sci Technol; 2020 Sep; 14(5):883-889. PubMed ID: 30854894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction.
    Patzer KH; Ardjomand P; Göhring K; Klempt G; Patzelt A; Redzich M; Zebrowski M; Emmerich S; Schnell O
    J Diabetes Sci Technol; 2018 May; 12(3):687-694. PubMed ID: 29532694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoglobin A1c: assessment of three POC analyzers relative to a central laboratory method.
    Petersen JR; Omoruyi FO; Mohammad AA; Shea TJ; Okorodudu AO; Ju H
    Clin Chim Acta; 2010 Dec; 411(23-24):2062-6. PubMed ID: 20832393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study).
    Kennedy L; Herman WH;
    Diabetes Technol Ther; 2005 Dec; 7(6):907-12. PubMed ID: 16386096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study.
    Barron E; Misra S; English E; John WG; Sampson M; Bachmann MO; Barth J; Oliver N; Alberti KGMM; Bakhai C; O'Neill S; Young B; Wareham NJ; Khunti K; Jebb S; Smith J; Valabhji J
    BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33318069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Point-of-Care Testing and Hospital-Based Methods in Screening for Potential Type 2 Diabetes Mellitus and Abnormal Glucose Regulation in a Dental Setting.
    Suwattipong M; Thuramonwong T; Tantipoj C; Fuangtharnthip P; Thanakun S; Khovidhunkit W; Khovidhunkit SP
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34203697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HbA
    Dubach IL; Christ ER; Diem P
    Prim Care Diabetes; 2019 Dec; 13(6):583-587. PubMed ID: 31175054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of Point-of-Care Testing Compared with the Standard Laboratory Diagnostic Test in the Measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects.
    Berbudi A; Rahmadika N; Tjahjadi AI; Ruslami R
    J Diabetes Res; 2020; 2020():2037565. PubMed ID: 32733964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value proposition for point-of-care testing in healthcare: HbA1c for monitoring in diabetes management as an exemplar.
    Price CP; St John A
    Scand J Clin Lab Invest; 2019 Sep; 79(5):298-304. PubMed ID: 31082284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of HbA1c Testing at Point of Care on Diabetes Management.
    Schnell O; Crocker JB; Weng J
    J Diabetes Sci Technol; 2017 May; 11(3):611-617. PubMed ID: 27898388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBA1C point-of-care testing for diabetes control in a low-income population: A before and after study and cost-parity analysis HbA1c point-of-care testing for diabetes control.
    Andrade MV; de Souza Noronha KVM; Santos AS; Maia JX; Nogueira LT; Cimini CCR; Furtado ME; Coelho L; Marcolino MS; Ribeiro ALP
    Prim Care Diabetes; 2023 Oct; 17(5):447-453. PubMed ID: 37543526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.